Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia

American Journal of Cardiology

Volumn 77, Issue 3, 1996, Pages 83A-88A

  Hellestrand, Kevin J ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; FLECAINIDE ACETATE;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART PALPITATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETHARGY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME; VERTIGO; VISUAL IMPAIRMENT;

EID: 0030053050     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89122-9     Document Type: Conference Paper

References (11)

1. Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala Z. Atrioventricular nodal reentiy: clinical, electrophysiological, and therapeutic considerations. Circulation 1993;88:282-295.
2. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
3. Anderson JL, Jolivette DM, Fredell PA. Summary of efficacy and safety of flecainide for supraventricular arrhythmias. Am J Cardiol 1988;62(suppl):62D-66D.
4. Clementy J, Dulhoste MN, Laiter C, Denjoy I, Dos Santos P. Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients. Am J Cardiol 1992;70(suppl):44A-49A.
5. Pritchett ELC, DaTorre SD, Platt ML, McCarville SE, Hougham AJ. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. J Am Coll Cardiol 1991;17:297-303.
6. Leclercq JF, Chouty F, Denjoy I, Coumel P, Slama R. Flecainide in quinidine-resistant atrial fibrillation. Am J Cardiol 1992;70(suppl):62A-65A.
7. Zee-Cheng C, Kim SS, Ruffy R. Flecainide acetate in the treatment of bypass tract mediated reentrant tachycardia. Am J Cardiol 1988;62(suppl):23D-28D.
8. Camm AJ, Katritsis D, Nunian SO. Effects of flecainide on atrial electrophysiology in the Wolff-Parkinson-White syndrome. Am J Cardiol 1992;70(suppl):33A-37A.
9. Anderson JL, for the Flecainide Supraventricular Tachyarrhythmia Investigators. Long term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. Am J Cardiol 1992; 70(suppl):11A-18A.
10. Neuss H, Schlepper M. Long term efficacy and safety of flecainide for Supraventricular tachycardia. Am J Cardiol 1988;62(suppl):56D-61D.
11. Pritchett ELC, Wilkinson WE. Mortality in patients treated with flecainide and encainide for Supraventricular arrhythmias. Am J Cardiol 1991;67:976-980.